Hong Kong Group Plans Subsidy For Costly Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
Hong Kong's Community Care Fund plans a nearly $9 million subsidy for expensive drugs for 1,000 seriously ill cancer patients